Seeing Is Believing
LTRN is currently covered by 1 analysts with an average price target of $10.81. This is a potential upside of $6 (124.74%) from yesterday's end of day stock price of $4.81.
Lantern Pharma's activity chart (see below) currently has 0 price targets and 8 ratings on display. The stock rating distribution of LTRN is 83.33% BUY and 16.67% HOLD.
Highest price target for LTRN is $5, Lowest price target is $4, average price target is $10.81.
Most recent stock forecast was given by MICHAEL KING from HCWAINWRIGHT on 10-Aug-2023. First documented stock forecast 07-Oct-2021.
Currently out of the existing stock ratings of LTRN, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$11
$5.93 (116.96%)
$11
1 years 6 months 2 days ago
(10-Aug-2023)
0/5 (0%)
$6 (120.00%)
What is LTRN (Lantern Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on LTRN (Lantern Pharma) with a proven track record?
Which analyst has the most public recommendations on LTRN (Lantern Pharma)?
Which analyst is the currently most bullish on LTRN (Lantern Pharma)?